Dabur Research Foundation

hideThis article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (December 2018) (Learn how and when to remove this template message) This article includes a list of references, related reading or external links, but its sources remain unclear because it lacks inline citations. Please help to improve this article by introducing more precise citations. (October 2012) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Dabur Research Foundation

Founded	1979
Headquarters	Sahibabad, Ghaziabad - 201010 (UP) , India
Parent	Dabur India Limited
Website	daburresearch.in

Dabur Research Foundation (DRF) is an Indian contract research organization offering pre-clinical services in drug discovery and development. It was established in 1979 to spearhead the research and development activities of Dabur, India's largest Ayurvedic medicine manufacturer.

References[]

• Articles about International Finance Corporation - Economic Times
• BioSpectrumIndia - the business of biotech - Customer relationships in a competitive market
• Elephant Capital buys stake in ClinTec Intl for Rs 58 cr
• Cosmetics testing kills 3.9 million animals - BioSpectrum Asia
• Burmans plan Rs 925-crore healthcare fund
• Dabur to re-expand its pharma research

Further reading[]

• Madaan, Alka; Singh, Pratibha; Awasthi, Anshumali; Verma, Ritu; Singh, Anu T.; Jaggi, Manu; Mishra, Shiva Kant; Kulkarni, Sadanand; Kulkarni, Hrishikesh (2012). "Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel". Clinical and Translational Oncology. 15 (1): 26–32. doi:10.1007/s12094-012-0883-2. PMID 22855169.
• Kumar, Vivek; Madaan, Alka; Sanna, Vinod K.; Vishnoi, Manupriya; Joshi, Narendra; Singh, Anu T.; Jaggi, Manu; Sharma, Pramod K.; et al. (2009). "Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives". Journal of Enzyme Inhibition and Medicinal Chemistry. 24 (5): 1169–78. doi:10.1080/14756360802696802. PMID 19555167.
• Bansal, Tripta; Jaggi, Manu; Khar, Roop K; Talegaonkar, Sushama (2009). "Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy". Journal of Pharmacy & Pharmaceutical Sciences. 12 (1): 46–78. CiteSeerX 10.1.1.557.474. PMID 19470292.

External links[]

• Official website

This article about an organisation in India is a stub. You can help Wikipedia by .

• v
• t